Announcing the new Editor-in-Chief of the European Journal of Endocrinology (EJE)
On behalf of the ESE Executive Committee, we are pleased to announce that the new Editor-in-Chief of our prestigious journal, the European Journal of Endocrinology (EJE), is Professor Wiebke Arlt.
Professor Hans Romijn will be stepping down as Editor-in-Chief at the end of this year. Hans has been Editor-in-Chief since 2011 and, together with the Editorial Board, has shown enormous commitment and determination to bring the journal to where it is today. Our thanks will always be with him.
Following a successful application and interview process held earlier this year, we are delighted that Wiebke has accepted this role. This is very good news for our beloved journal, as we know the excellent work of Hans will be in safe hands.
I studied Medicine at the University of Cologne, Germany, graduating in 1990, followed by general medical training and an academic MD degree (2003; “summa cum laude”, with highest distinction), supervised by Bruno Allolio. From 1994-1998, I undertook my specialist training in Endocrinology & Diabetes at the University Hospital Würzburg, Germany, mentored by Bruno Allolio. As a DFG Postdoctoral Research Fellow I trained in Molecular Endocrinology at the University of California at San Francisco, USA (Host: Walter Miller; 1999-2001). In 2002, I joined the University of Birmingham, UK, with a DFG Heisenberg Senior Fellowship, following an invitation by Paul Stewart. In 2004, I was awarded a Medical Research Council (MRC) Senior Fellowship to continue my research in Birmingham. I was promoted to Professor of Medicine in 2006 and to the William Withering Chair in Medicine in 2014. Since 2015, I am the founding Director of the Institute of Metabolism and Systems Research (IMSR) at the University of Birmingham, where I lead a multi-disciplinary research group and direct the Steroid Metabolome Analysis Core. My research investigates the role of steroid metabolism in human health and disease, with translational focus on androgen excess and adrenal disease, funded by Wellcome Trust, MRC and EU.